Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
6.85
-0.07 (-1.01%)
Nov 17, 2026, 2:46 PM EST - Market open

Envoy Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
53192935--
Market Cap Growth
175.92%-34.26%-18.21%---
Enterprise Value
39164029--
Last Close Price
6.926.6114.3018.11100.2097.40

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
231.3378.97128.67112.02--
PB Ratio
--1.62-1.54-19.93--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
171.6268.14178.3890.34--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.68-0.08-1.04-0.32-0.95-0.94
Net Debt / Equity Ratio
12.100.24-0.752.06-0.95-0.89
Net Debt / EBITDA Ratio
0.590.13-0.740.20-3.98-3.29
Net Debt / FCF Ratio
0.620.15-0.750.21-3.81-3.17
Asset Turnover
0.020.020.020.060.09-
Inventory Turnover
0.540.420.480.590.42-
Quick Ratio
1.030.330.840.610.090.87
Current Ratio
1.210.541.181.020.651.76
Return on Assets (ROA)
-108.38%-137.34%-121.51%-211.96%-210.09%-
Return on Capital Employed (ROCE)
-484.90%735.00%-481.40%-1862.00%-23529.70%-554.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-49.49%-124.83%-71.83%-84.53%--
FCF Yield
-41.99%-96.58%-65.39%-48.72%--
Buyback Yield / Dilution
-264.88%-23.78%-52.83%-21.46%0.04%-
SEC Filings: 10-K · 10-Q